Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OS6P
|
|||
| Drug Name |
XBIO-101
|
|||
| Synonyms |
sodium cridanimod; cridanimod; Cridanimod; 38609-97-1; 9-Oxo-10(9H)-acridineacetic acid; 10-Carboxymethyl-9-acridanone; N-(Carboxymethyl)acridone; (9-oxoacridin-10(9H)-yl)acetic acid; 10(9H)-ACRIDINEACETIC ACID, 9-OXO-; Cridanimod [INN]; 2-(9-oxoacridin-10(9H)-yl)acetic acid; (9-Oxo-9H-acridin-10-yl)-acetic acid; UNII-X91E9EME19; 10-Carboxymeth-9-acridanone; Cycloferon; BRN 0227508; 9-Oxo-10-acridanacetic acid; X91E9EME19; C15H11NO3; Cridanimod (INN); 2-(9-oxoacridin-10-yl)acetic acid; 10(9H)-Acridineaceticacid, 9-oxo-; (9-Oxo-10(9H)-acrid
Click to Show/Hide
|
|||
| Indication | Endometrial cancer [ICD-11: 2C76; ICD-9: 182] | Phase 2 | [1] | |
| Malignant uterine tumour [ICD-11: 2C76.Z] | Phase 2 | [2] | ||
| Company |
Xenetic Biosciences Lexington, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H11NO3
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CC(=O)O
|
|||
| InChI |
1S/C15H11NO3/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16/h1-8H,9H2,(H,17,18)
|
|||
| InChIKey |
UOMKBIIXHQIERR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 38609-97-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:136036
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.